Literature DB >> 22790276

The utility of pathogen inactivation technology: a real-life example of Leishmania infantum inactivation in platelets from a donor with an asymptomatic infection.

Teresa Jimenez-Marco1, Cristina Riera, Roser Fisa, Enrique Girona-Llobera, Matilde Sedeño, Raymond P Goodrich, Alba Pujol, Carmen Guillen, Josep Muncunill.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22790276      PMCID： PMC3496220          DOI： 10.2450/2012.0178-11

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  30 in total

1.  Leishmania donovani transmission by packed RBC transfusion to anemic dogs in the United States.

Authors:  Urs Giger; Donna A Oakley; Sean D Owens; Peter Schantz
Journal:  Transfusion       Date:  2002-03       Impact factor: 3.157

2.  Requirements of defined cultivation conditions for standard growth of Leishmania promastigotes in vitro.

Authors:  J L Lemesre; F Darcy; M Kweider; A Capron; F Santoro
Journal:  Acta Trop       Date:  1988-06       Impact factor: 3.112

3.  Optimized PCR using patient blood samples for diagnosis and follow-up of visceral Leishmaniasis, with special reference to AIDS patients.

Authors:  L Lachaud; J Dereure; E Chabbert; J Reynes; J M Mauboussin; E Oziol; J P Dedet; P Bastien
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Transfusion-transmitted visceral leishmaniasis caused by Leishmania (Leishmania) mexicana in an immunocompromised patient: a case report.

Authors:  Laureano Mestra; Liliana Lopez; Sara M Robledo; Carlos E Muskus; Rubén S Nicholls; Iván Darío Vélez
Journal:  Transfusion       Date:  2011-03-10       Impact factor: 3.157

5.  Septic shock due to visceral leishmaniasis, probably transmitted from blood transfusion.

Authors:  Maria A Mpaka; Zoi Daniil; Despina S Kyriakou; Epaminondas Zakynthinos
Journal:  J Infect Dev Ctries       Date:  2009-07-01       Impact factor: 0.968

6.  Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic.

Authors:  Alberto Biglino; Cesare Bolla; Erika Concialdi; Anna Trisciuoglio; Angelo Romano; Ezio Ferroglio
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

7.  The first probable case of platelet transfusion-transmitted visceral leishmaniasis.

Authors:  P Mathur; J C Samantaray
Journal:  Transfus Med       Date:  2004-08       Impact factor: 2.019

8.  Quick detection of Leishmania in peripheral blood by flow cytometry. Is prestorage leucodepletion necessary for leishmaniasis prevention in endemic areas?

Authors:  D S Kyriakou; M G Alexandrakis; F H Passam; T V Kourelis; P Foundouli; E Matalliotakis; A N Maniatis
Journal:  Transfus Med       Date:  2003-04       Impact factor: 2.019

9.  A nested polymerase chain reaction for diagnosis and follow-up of human visceral leishmaniasis patients using blood samples.

Authors:  R Fisa; C Riera; E Ribera; M Gállego; M Portús
Journal:  Trans R Soc Trop Med Hyg       Date:  2002-04       Impact factor: 2.184

10.  Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods.

Authors:  C Riera; R Fisa; M Udina; M Gállego; M Portus
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-02       Impact factor: 2.184
View more
  4 in total

1.  Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach.

Authors:  Teresa Jimenez-Marco; Cristina Riera; Enrique Girona-Llobera; Carmen Guillen; Laura Iniesta; Magdalena Alcover; Diana Berenguer; Alba Pujol; Miriam Tomás-Pérez; Beatriz Cancino-Faure; Teresa Serra; Martín Mascaró; Joan Gascó; Roser Fisa
Journal:  Blood Transfus       Date:  2017-03-15       Impact factor: 3.443

2.  Haemostatic function measured by thromboelastography and metabolic activity of platelets treated with riboflavin and UV light.

Authors:  Carme Ballester-Servera; Teresa Jimenez-Marco; Daniel Morell-Garcia; Miguel Quetglas-Oliver; Antonia M Bautista-Gili; Enrique Girona-Llobera
Journal:  Blood Transfus       Date:  2020-05-15       Impact factor: 3.443

3.  Case Report: Diffuse Cutaneous Leishmaniasis by Leishmania infantum in a Patient Undergoing Immunosuppressive Therapy: Risk Status in an Endemic Mediterranean Area.

Authors:  M Magdalena Alcover; Vicenç Rocamora; M Carmen Guillén; Diana Berenguer; Marta Cuadrado; Cristina Riera; Roser Fisa
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

4.  Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.

Authors:  Andrew P Cap; Heather F Pidcoke; Shawn D Keil; Hilary M Staples; Manu Anantpadma; Ricardo Carrion; Robert A Davey; Ashley Frazer-Abel; Audra L Taylor; Richard Gonzales; Jean L Patterson; Raymond P Goodrich
Journal:  Transfusion       Date:  2016-03       Impact factor: 3.157
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.